Rejuve.Bio

Rejuve.Bio

Early Stage

AI for healthy human longevity

AI for healthy human longevity

Overview

Raised to Date: Raised: $112,572

Total Commitments ($USD)

Platform

Netcapital

Start Date

02/20/2024

Close Date

04/25/2024

Min. Goal
$10,004
Max. Goal
$4,999,999
Min. Investment

$100

Security Type

Equity - Common

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$8.33

Pre-Money Valuation

$39,984,000

Rolling Commitments ($USD)

Status

Active

Reporting Date

04/15/2024

Days Remaining

10

% of Min. Goal

1,125%

% of Max. Goal

2%

Likelihood of Max
unlikely
Avg. Daily Raise

$2,047

Momentum
cold.svg
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2022

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Location

Orange, California

Rejuve.Bio, with a valuation of $39.9 million, is raising funds on NetCapital. The company aims to leverage advanced AI technology and data-driven approaches to extend the human health span and revolutionize longevity treatments. Rejuve.Bio plans to develop therapeutics that reduce the impact of aging and aging-related diseases. The business has tested its products on test flies and has increased their lifespan by 4.5 times. Kennedy Schaal founded Rejuve.Bio in December 2022. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $5 million. The campaign proceeds will be used for product development and go-to-market marketing expenses.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$0

$0

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$0

$0

Accounts Receivable

$0

$0

Total Assets

$0

$0

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Financials as of: 02/20/2024
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Rejuve.Bio on NetCapital 2024
Platform: Netcapital
Security Type: Equity - Common
Valuation: $39,984,000
Price per Share: $8.33

Follow company

Follow Rejuve.Bio on NetCapital 2024

Buy Rejuve.Bio's Deal Report

Rejuve.Bio Deal Report

Get KingsCrowd’s comprehensive report on Rejuve.Bio including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Rejuve.Bio is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Rejuve.Bio deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge